Board of Pharmacy Dr. Stephanie Johnican Confirmation Resolution of 2026

26th Council Period (2025-2026) Introduced by Phil Mendelson

Dr. Stephanie Johnican is confirmed to serve on the DC Board of Pharmacy, guiding licensure, practice standards, and governance for pharmacists in DC.

Approved with Resolution Number R26-0429

Summary of PR 26-0690 — Board of Pharmacy Dr. Stephanie Johnican Confirmation Resolution of 2026

What this bill does

This resolution confirms the appointment of Dr. Stephanie Johnican as a pharmacist licensed in the District of Columbia to serve on the District of Columbia Board of Pharmacy.

She fills a vacant seat previously held by Alan Friedman.

The initial term runs for the remainder of an unexpired term ending March 12, 2026, with a subsequent full term ending March 12, 2029.

Main purpose and intent

To validate, via formal Council confirmation, Dr. Johnican’s appointment to the Board of Pharmacy, ensuring continued governance and oversight of pharmacy practice in the District.

Aligns with statutory authority: confirmation under the DC Confirmation Act of 1978 and section 208 of the Health Occupations Revision Act of 1985.

Key provisions and changes

Identification of appointee: Dr. Stephanie Johnican, 7th Street, SW, Washington, DC 20024 (Ward 6).

Position: Pharmacist licensed in DC, member of the Board of Pharmacy.

Term details:

Unexpired term: ends March 12, 2026.
Subsequent term: ends March 12, 2029.

Administrative steps:

Council confirmation required and once adopted, a copy of the resolution must be transmitted to the nominee and to the Mayor’s Office.
Resolution takes effect immediately upon adoption.

Who is affected

Dr. Stephanie Johnican becomes a board member, contributing to licensing, regulation, and professional standards for pharmacists in DC.

The Board of Pharmacy gains another practicing pharmacist with diverse state licenses (DC, Kentucky, California, Maryland, Virginia) and relevant clinical experience.

Procedural and timeline aspects

Nomination presented by Mayor Muriel Bowser on May 4, 2026.

Action history shows referral to the Committee on Health on May 19, 2026; introduced May 4, 2026.

Legal sufficiency review completed by the Mayor’s Office, confirming no legal objections to the nomination.

Once adopted by the Council, the resolution is effective immediately.

Additional context about the nominee

Dr. Johnican’s current role: Primary Care Clinical Pharmacist at the Washington DC VA Medical Center (as of 2023–present).

Prior roles include Clinical Pharmacist at the Oakland VA Outpatient Clinic (2015–2022).

Education and credentials reflect a Doctor of Pharmacy and multiple licenses across several states, as well as relevant certifications (e.g., MTM, immunization, anticoagulation, and diabetes care).

Practical impact

Ensures regulatory leadership continuity on the Board of Pharmacy.

Supports ongoing governance of pharmacist licensure, scope of practice, licensure violations, and professional standards within DC.

The immediate effect is the formal confirmation of the appointment, enabling Dr. Johnican to participate in Board activities for the specified terms.